Clinical Trial Update: Metabolic Imaging of Neurological Disease

View source ↗

Summary

A University of Oxford-sponsored clinical trial update on metabolic imaging for Multiple Sclerosis, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: University of Oxford | Conditions: Multiple Sclerosis | Status: ENROLLING_BY_INVITATION